MRI Characteristics of Low-Grade Glioma
Low-grade gliomas in young adults presenting with seizures typically appear as nonenhancing, T2/FLAIR hyperintense lesions without mass effect or surrounding edema on MRI. 1
Core Anatomic Imaging Features
Essential MRI sequences for identifying low-grade gliomas include T1-weighted (pre- and post-gadolinium), T2-weighted, and FLAIR imaging. 2 These sequences form the minimum diagnostic standard for suspected brain tumors. 2
T1-Weighted Characteristics
- Hypointense (low signal) on non-contrast T1-weighted images 1
- Typically non-enhancing after gadolinium administration, distinguishing them from high-grade gliomas 1
- Lack of contrast enhancement is a hallmark feature in most low-grade gliomas 1
T2-Weighted and FLAIR Characteristics
- Hyperintense (bright) signal on T2-weighted and FLAIR sequences 1, 2
- Well-demarcated appearance, particularly in oligodendrogliomas 1
- Solid, homogeneous signal intensity without significant heterogeneity 1
Additional Structural Features
- Absence of mass effect despite potentially large tumor size 1
- No peritumoural edema, which helps differentiate from high-grade tumors 1
- Low-attenuation on CT imaging when this modality is used 1
Tumor-Specific Imaging Patterns
Oligodendrogliomas
- Calcifications present in over one-third of cases, best visualized on CT 1
- Well-demarcated borders with sharp margins 1
- Cortical location with potential skull remodeling (44% of cases) 1
Astrocytomas
- Poorly circumscribed and infiltrative appearance 1
- More diffuse borders compared to oligodendrogliomas 1
- Less likely to contain calcifications 1
Advanced Imaging Characteristics
Perfusion MRI Findings
Low cerebral blood volume (rCBV) with values typically <1.75 distinguishes low-grade from high-grade gliomas. 3 The average rCBV for low-grade gliomas is approximately 1.29 (range 0.01-5.10), significantly lower than high-grade tumors. 3
Dynamic susceptibility contrast (DSC) perfusion imaging shows:
- Minimal tumor perfusion reflecting low angiogenesis 2
- Absence of increased vascular permeability 3
- Hypoperfusion on interictal SPECT imaging 1
Metabolic Imaging
FDG-PET demonstrates glucose hypometabolism in low-grade gliomas, showing minimal metabolic activity. 1 This contrasts sharply with high-grade tumors that show increased glucose uptake. 1
MET-PET shows minimal or absent uptake of 11C-methionine, which is highly suggestive of low-grade pathology when combined with slowly progressive clinical course. 1
MR Spectroscopy
- Loss of N-acetylaspartate (NAA) is less pronounced than in high-grade gliomas 1
- Choline elevation is present but less dramatic than high-grade tumors 1
- May help identify progression to higher grade when serial studies show increasing choline 2
Critical Differential Diagnosis Considerations
Low-grade gliomas must be distinguished from focal cortical dysplasia (FCD), which can have overlapping imaging features in seizure patients. 1 Key differentiating features include:
- FCD shows blurring of grey-white matter junction more prominently 1
- Transmantle sign (radially oriented T2/FLAIR hyperintensity pointing to ventricle) is specific for FCD type IIb, not glioma 1
- FCD demonstrates cortical thickening and abnormal gyral patterns 1
Dysembryoplastic neuroepithelial tumors (DNETs) are another important differential:
- Intracortical location without mass effect (similar to low-grade glioma) 1
- May show skull deformity overlying the lesion 1
- Hypoperfusion on interictal SPECT with epileptogenic cortex surrounding (not within) the lesion 1
Gangliogliomas can mimic low-grade gliomas and represent a key histological differential diagnosis. 1
Surveillance Imaging Protocol
Serial T2/FLAIR sequences are essential for monitoring tumor growth and detecting malignant transformation. 1, 2 Follow-up imaging should be performed every 3-6 months initially. 1
New contrast enhancement or significant size increase signals potential transformation to higher grade, requiring immediate clinical action. 1, 2 This represents a critical imaging milestone that changes management from observation to intervention. 1
Common Pitfalls
Approximately 21% of low-grade gliomas show some contrast enhancement, which can lead to misclassification as high-grade tumors. 1 Clinical context and perfusion characteristics help resolve this ambiguity. 3
Small cystic components occur in 7.5% of cases, which should not automatically suggest higher grade pathology. 1
Biopsy sampling error is significant because gliomas have regional heterogeneity, and small samples may underestimate grade. 1 Imaging-guided targeting of areas with highest perfusion improves diagnostic accuracy. 2
High-grade gliomas occasionally present without enhancement, mimicking low-grade tumors on conventional MRI. 3 Perfusion imaging showing rCBV >1.75 helps identify these cases. 3